Paper Details

  1. Home
  2. Paper Details

Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease.

Author: AkobengA K, ZachosM

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Crohn’s disease can be difficult to treat, and some patients don’t respond to standard treatments like corticosteroids, enteral nutrition, and immunosuppressants. Some people also become dependent on steroids, which can lead to side effects. Recent studies suggest that medications that block tumor necrosis factor (TNF)-alpha may be effective in inducing remission in Crohn’s disease.
Paper Details　
Original Abstract of the Article :
Crohn's disease may be refractory to conventional treatments such as corticosteroids, enteral nutrition and immuno-suppressive agents. A number of patients with the disease may also become steroid-dependent leading to increased risk of developing steroid-related adverse effects. Recent studies sugge...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721561/

データ提供：米国国立医学図書館（NLM）

Crohn's Disease: A Journey Through the Desert of Inflammation

Crohn's disease, an inflammatory bowel disease, is a challenging condition that can be likened to a relentless desert sandstorm, wreaking havoc on the digestive system. This study explores the potential of TNF-alpha blocking agents as a new approach to inducing remission in Crohn's disease.

TNF-alpha is a powerful inflammatory molecule that plays a central role in the progression of Crohn's disease, like a raging sandstorm that threatens to engulf the oasis of health. By blocking TNF-alpha, researchers are aiming to calm the storm and promote healing.

TNF-alpha Blocking Agents: A New Hope for Crohn's Disease

The study suggests that TNF-alpha blocking agents may be an effective treatment for Crohn's disease, especially for patients who have not responded well to traditional therapies. It's like finding a new spring of water in the desert, offering hope for those who have struggled to find relief.

Navigating the Desert of Inflammatory Bowel Disease

This research highlights the importance of exploring new avenues for treating Crohn's disease, like finding a new path through a vast and unforgiving desert. It's a search for a more effective and targeted approach to combatting inflammation and restoring health and well-being.

Dr.Camel's Conclusion

This study sheds light on the potential of TNF-alpha blocking agents in treating Crohn's disease. It's like discovering a new oasis in the desert of inflammatory bowel disease, offering a promising alternative for those seeking relief from this debilitating condition.

Date :
  1. Date Completed 2004-06-29
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

14974022

DOI: Digital Object Identifier

PMC8721561

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.